search
Back to results

Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension

Primary Purpose

Hypotension, Anesthesia

Status
Completed
Phase
Phase 4
Locations
Pakistan
Study Type
Interventional
Intervention
Phenylephrine Hydrochloride 4 mg
Phenylephrine Hydrochloride 8 mg
Sponsored by
Rehman Medical Institute - RMI
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypotension focused on measuring Cesarean section.

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • All pregnant ladies of American Society of Anesthesiologists (ASA) physical status 1 or 2 with
  • Singleton Pregnancy,
  • Full term pregnancy, and
  • Admitted for elective CS

Exclusion Criteria:

All those participants having;

  • Blood pressure ≥140/90 mm of Hg,
  • ASA 3 or above status,
  • Contraindication to spinal anesthesia
  • Fetal anomalies/
  • Abnormal placentae
  • Refusal to consent

Sites / Locations

  • Rehman Medical Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Phenylephrine 4mg

Phenylephrine 8mg

Arm Description

Inj Phenylephrine HCL 04 mg as Group P4.

Inj Phenylephrine HCL 08 mg as Group P8.

Outcomes

Primary Outcome Measures

Incidence of hypotension in both groups
The primary outcome is to find incidence of hypotension in each group P4 and P8 i.e. number of participants who develop hypotension in the relevant group multiplied by 100. Incidence= number of participants who develop hypotension/ total participants in the group *100. Hypotension is defined as a decrease of more than 20 % from baseline systolic blood pressure measured through non-invasive method.

Secondary Outcome Measures

To find the rescue dose/ doses of intravenous Phenylephrine HCL.
To find the rescue dose/ doses of intravenous Phenylephrine in the two groups P4 and P8.
Onset of hypotension
Determine the onset of hypotension in the two groups P4 and P8 (keeping starting time 0 minute at the administration of intrathecal hyperbaric Bupivacaine).
Adverse events associated with any groups
Record any adverse event associated with any groups e.g. bradycardia, hypotension, Nausea, Vomiting, Hypertension, Cardiac arrest.
Neonatal APGAR Score
Neonatal APGAR (Appearance, Pulse, Grimace response, Activity, and Respiration)Score from 0 - 10 will be measured at 01 and 05 minutes for each neonate delivered. The higher score is considered good i.e. 10 while lower score is considered bad/ worse e.g. 0 -3. The Apgar score measures five things to check a baby's health. Each is scored on a scale of 0 to 2, with 2 being the best score: Appearance (skin color) Pulse (heart rate) Grimace response (reflexes) Activity (muscle tone) Respiration (breathing rate and effort)

Full Information

First Posted
April 4, 2022
Last Updated
April 21, 2022
Sponsor
Rehman Medical Institute - RMI
search

1. Study Identification

Unique Protocol Identification Number
NCT05348980
Brief Title
Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension
Official Title
Comparison of Two Different Doses of Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension During Cesarean Section: A Prospective Randomized Double-blinded Parallel Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
January 1, 2020 (Actual)
Primary Completion Date
July 31, 2020 (Actual)
Study Completion Date
July 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rehman Medical Institute - RMI

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Background: Spinal anesthesia (SA) is preferred over general anesthesia in Cesarean section (CS) due to its better safety profile but SA induced hypotension remains a big challenge for the clinical Anesthetist. Different methods including 15° left lateral table tilt, leftward uterine manual displacement, fluid pre-and co-loading have been used but drop in Systolic Blood Pressure (SBP) jeopardizing maternal and fetal well-being still occurs. Timely administered Phenylephrine HCL, an α-1 adrenergic agonist, is a recommended remedy. Subjects and methods: Sixty parturients of American Society of Anaesthesiologists (ASA) physical status 1 and 2, scheduled for elective CS under SA were enrolled in this prospective double-blinded study and randomly divided into two equal groups, P4 and P8. They received intramuscular (IM) Phenylephrine HCL 04 mg and 08 mg respectively before SA. Spinal block up to T6 was achieved with 12.5 mg 0.5% Bupivacaine HCl heavy. The incidence and intensity of hypotension, rescue doses of Phenylephrine HCL and any adverse event, were recorded. Data collected was analyzed using Epi lnfo ™ version 7.2.
Detailed Description
Introduction: World Health Organization (WHO) defines maternal death as a death while pregnant or within 42 days of the end of gestation, from any cause related to or aggravated by the pregnancy or its management (excluding accidental or incidental causes). In 2017 global Maternal Mortality Ratio (MMR) reported by United Nations (UN) is 211 deaths per 100,000 live births. MMR in Pakistan, with inter-provincial variability, is 186 deaths per 100,000 live births according to the latest Pakistan Maternal Mortality Survey (PMMS) report published in August, 2020 by United Nations Population Fund (UNFPA), a subsidiary organ of United Nations General Assembly. CS requires general anesthesia, SA or epidural anesthesia; however, SA is preferred. SA is believed to be safe, though severe complications like profound hypotension compounded by aorto-caval compression might happen . World Health Organization (WHO) defines ideal CS rate below 10 to 15 %. According to 1990-91 and 2017-18 Pakistan Demographic and Health Survey data, rate of C-section has been raised from 3.2 % to 19.6 - 22.3 % . Higher rate of anesthesia and surgery in a developing country like Pakistan has a direct bearing on MMR, patient's morbidity, cost of medical services and siphoning scarce resources. The first case of cardiac arrest occurring after SA was reported in 1940 and since then, the ability of SA to cause cardio-pulmonary arrest was considered. Hypotension and bradycardia are the most common side effects of SA. SA induced hypotension, which is a substantial clinical challenge, is caused by pharmacological sympathectomy. The incidence is reported around 80 %. Hypotension occurs despite fluid preload, left lateral uterine displacement and left lateral table tilt. Duration and severity of hypotension is responsible for maternal ill effects like nausea/vomiting initially and later culminating to dyspnoea, apnea and circulatory arrest if poorly managed. Additionally there will be poor apgar score or even fetal demise depending upon the severity. Energetic use of strong vasopressors has been recommended. Phenylephrine HCL is considered to be the vasopressor of choice in parturients due to its propensity to cause less fetal acidosis. Phenylephrine HCL being an α-1adrenergic agonist counters the decrease in Systemic Vascular Resistance (SVR) induced by SA and can be administered by subcutaneous, intravenous and IM routes. Its onset and duration of action are 1-3 minutes and 5- 20 minutes respectively, when given intravenously (IV); and 10-20 minutes and an hour respectively when given IM. Clinically, 50-100 microgram boluses of Phenylephrine HCL is used intravenously to address hypotension. The investigators, in the current study exploited its lesser reported IM route. Rationale: IM Phenylephrine HCL shortly before administering SA can prove a better option to prevent hypotension even for longer duration due to its slower absorption and can provide longer hemodynamic stability, lesser drop in fetal pH and apgar score. Objectives: The primary objective of the study was to determine appropriate dose of IM Phenylephrine HCL in preventing hypotension due to SA administered for CS in ASA 1 and 2 parturients. Secondary objectives were to determine the need for total rescue doses of Phenylephrine HCL, measure drop in SBP in the two trial groups; and observe any side effects associated with IM injection of Phenylephrine HCL.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension, Anesthesia
Keywords
Cesarean section.

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
The study design was prospective double-blinded randomized parallel with allocation ratio of 1:1.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Two color coded envelops containing drug doses for intervention.
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Phenylephrine 4mg
Arm Type
Active Comparator
Arm Description
Inj Phenylephrine HCL 04 mg as Group P4.
Arm Title
Phenylephrine 8mg
Arm Type
Active Comparator
Arm Description
Inj Phenylephrine HCL 08 mg as Group P8.
Intervention Type
Drug
Intervention Name(s)
Phenylephrine Hydrochloride 4 mg
Other Intervention Name(s)
Injection Synephrine (Atco Laboratories Ltd. Pakistan
Intervention Description
Intramuscular Phenylephrine HCL 04 mg were administered as prophylactic stat dose in Vastus lateralis muscle of thigh 05 minutes before giving spinal anesthesia.
Intervention Type
Drug
Intervention Name(s)
Phenylephrine Hydrochloride 8 mg
Other Intervention Name(s)
Injection Synephrine (Atco Laboratories Ltd. Pakistan
Intervention Description
Intramuscular Phenylephrine HCL 08 mg were administered as prophylactic stat dose in Vastus lateralis muscle of thigh 05 minutes before giving spinal anesthesia.
Primary Outcome Measure Information:
Title
Incidence of hypotension in both groups
Description
The primary outcome is to find incidence of hypotension in each group P4 and P8 i.e. number of participants who develop hypotension in the relevant group multiplied by 100. Incidence= number of participants who develop hypotension/ total participants in the group *100. Hypotension is defined as a decrease of more than 20 % from baseline systolic blood pressure measured through non-invasive method.
Time Frame
One and half hour post spinal anesthesia
Secondary Outcome Measure Information:
Title
To find the rescue dose/ doses of intravenous Phenylephrine HCL.
Description
To find the rescue dose/ doses of intravenous Phenylephrine in the two groups P4 and P8.
Time Frame
One and half hour post spinal anesthesia
Title
Onset of hypotension
Description
Determine the onset of hypotension in the two groups P4 and P8 (keeping starting time 0 minute at the administration of intrathecal hyperbaric Bupivacaine).
Time Frame
Half hour/ 30 minutes post spinal anesthesia
Title
Adverse events associated with any groups
Description
Record any adverse event associated with any groups e.g. bradycardia, hypotension, Nausea, Vomiting, Hypertension, Cardiac arrest.
Time Frame
One and half hour post spinal anesthesia
Title
Neonatal APGAR Score
Description
Neonatal APGAR (Appearance, Pulse, Grimace response, Activity, and Respiration)Score from 0 - 10 will be measured at 01 and 05 minutes for each neonate delivered. The higher score is considered good i.e. 10 while lower score is considered bad/ worse e.g. 0 -3. The Apgar score measures five things to check a baby's health. Each is scored on a scale of 0 to 2, with 2 being the best score: Appearance (skin color) Pulse (heart rate) Grimace response (reflexes) Activity (muscle tone) Respiration (breathing rate and effort)
Time Frame
5 minutes post delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All pregnant ladies of American Society of Anesthesiologists (ASA) physical status 1 or 2 with Singleton Pregnancy, Full term pregnancy, and Admitted for elective CS Exclusion Criteria: All those participants having; Blood pressure ≥140/90 mm of Hg, ASA 3 or above status, Contraindication to spinal anesthesia Fetal anomalies/ Abnormal placentae Refusal to consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohammad Shafiq, FCPS
Organizational Affiliation
Rehman Medical Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rehman Medical Institute
City
Peshawar
State/Province
Khyber Pakhtunkhwa
ZIP/Postal Code
25000
Country
Pakistan

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data including clinical and demographic characteristics, not affecting patient's confidentiality, will be shared.
IPD Sharing Time Frame
April, 2022 to April, 2025.
IPD Sharing Access Criteria
IPD will be shared on inter institutional request basis.
Citations:
PubMed Identifier
32790681
Citation
Shitemaw T, Jemal B, Mamo T, Akalu L. Incidence and associated factors for hypotension after spinal anesthesia during cesarean section at Gandhi Memorial Hospital Addis Ababa, Ethiopia. PLoS One. 2020 Aug 13;15(8):e0236755. doi: 10.1371/journal.pone.0236755. eCollection 2020.
Results Reference
background
PubMed Identifier
34127491
Citation
Michelsen TM, Tronstad C, Rosseland LA. Blood pressure and cardiac output during caesarean delivery under spinal anaesthesia: a prospective cohort study. BMJ Open. 2021 Jun 14;11(6):e046102. doi: 10.1136/bmjopen-2020-046102.
Results Reference
background
Citation
Richards E, Lopez MJ, Maani C V. Phenylephrine. xPharm Compr Pharmacol Ref [Internet]. 2021 Jul 13 [cited 2022 Jan 17];1-5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534801/
Results Reference
background
PubMed Identifier
27733286
Citation
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1775-1812. doi: 10.1016/S0140-6736(16)31470-2. Erratum In: Lancet. 2017 Jan 7;389(10064):e1.
Results Reference
result
PubMed Identifier
33267787
Citation
Amjad A, Imran A, Shahram N, Zakar R, Usman A, Zakar MZ, Fischer F. Trends of caesarean section deliveries in Pakistan: secondary data analysis from Demographic and Health Surveys, 1990-2018. BMC Pregnancy Childbirth. 2020 Dec 2;20(1):753. doi: 10.1186/s12884-020-03457-y.
Results Reference
result
PubMed Identifier
32581577
Citation
Ferre F, Martin C, Bosch L, Kurrek M, Lairez O, Minville V. Control of Spinal Anesthesia-Induced Hypotension in Adults. Local Reg Anesth. 2020 Jun 3;13:39-46. doi: 10.2147/LRA.S240753. eCollection 2020.
Results Reference
result
PubMed Identifier
33109924
Citation
Rijs K, Mercier FJ, Lucas DN, Rossaint R, Klimek M, Heesen M. Fluid loading therapy to prevent spinal hypotension in women undergoing elective caesarean section: Network meta-analysis, trial sequential analysis and meta-regression. Eur J Anaesthesiol. 2020 Dec;37(12):1126-1142. doi: 10.1097/EJA.0000000000001371.
Results Reference
result
Citation
EVALUATION OF PREEMPTIVE INTRAMUSCULAR EPHEDRINE VS PHENYLEPHRINE IN PREVENTION OF HYPOTENSION INDUCED BY SPINAL ANESTHESIA IN LOWER SEGMENT CAESAREAN SECTION. [cited 2021 Dec 18]; Available from: www.ijmedicines.com
Results Reference
result
PubMed Identifier
25635593
Citation
Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015 Apr;122(4):736-45. doi: 10.1097/ALN.0000000000000601.
Results Reference
result
PubMed Identifier
30335625
Citation
Hasanin AM, Amin SM, Agiza NA, Elsayed MK, Refaat S, Hussein HA, Rouk TI, Alrahmany M, Elsayad ME, Elshafaei KA, Refaie A. Norepinephrine Infusion for Preventing Postspinal Anesthesia Hypotension during Cesarean Delivery: A Randomized Dose-finding Trial. Anesthesiology. 2019 Jan;130(1):55-62. doi: 10.1097/ALN.0000000000002483.
Results Reference
result
PubMed Identifier
30687737
Citation
Wang X, Shen X, Liu S, Yang J, Xu S. The Efficacy and Safety of Norepinephrine and Its Feasibility as a Replacement for Phenylephrine to Manage Maternal Hypotension during Elective Cesarean Delivery under Spinal Anesthesia. Biomed Res Int. 2018 Dec 31;2018:1869189. doi: 10.1155/2018/1869189. eCollection 2018.
Results Reference
result
PubMed Identifier
30639574
Citation
Xu C, Liu S, Qian D, Liu A, Liu C, Chen Y, Qi D. Preventive intramuscular phenylephrine in elective cesarean section under spinal anesthesia: A randomized controlled trial. Int J Surg. 2019 Feb;62:5-11. doi: 10.1016/j.ijsu.2018.12.014. Epub 2019 Jan 11.
Results Reference
result
PubMed Identifier
24920942
Citation
Oh AY, Hwang JW, Song IA, Kim MH, Ryu JH, Park HP, Jeon YT, Do SH. Influence of the timing of administration of crystalloid on maternal hypotension during spinal anesthesia for cesarean delivery: preload versus coload. BMC Anesthesiol. 2014 May 16;14:36. doi: 10.1186/1471-2253-14-36. eCollection 2014.
Results Reference
result
PubMed Identifier
29090733
Citation
Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, Palanisamy A, Sia ATH, Van de Velde M, Vercueil A; Consensus Statement Collaborators. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018 Jan;73(1):71-92. doi: 10.1111/anae.14080. Epub 2017 Nov 1. No abstract available.
Results Reference
result
PubMed Identifier
30389535
Citation
Xu C, Liu S, Huang Y, Guo X, Xiao H, Qi D. Phenylephrine vs ephedrine in cesarean delivery under spinal anesthesia: A systematic literature review and meta-analysis. Int J Surg. 2018 Dec;60:48-59. doi: 10.1016/j.ijsu.2018.10.039. Epub 2018 Oct 31.
Results Reference
result

Learn more about this trial

Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension

We'll reach out to this number within 24 hrs